FOXM1 and cancer: However, deregulated FOXM1 signalling in cancer is involved in cell migration [33, 34], invasion [35, 36], angiogenesis [37, 38], stem cell renewal [39, 40], DNA damage repair and cellular senescence [41, 42], which impact tumor initiation [43, 44], progression, metastasis, angiogenesis and drug resistance [45].